Utah Performing Arts Center
The George S. and Dolores Dore Eccles Theater

FDA was hired by GTS Development for Salt Lake County to conduct a feasibility study and develop a program for the Utah Performing Arts Center. FDA worked closely with GTS and the County to plan and implement an architectural selection process, which led to the selection of Pelli Clarke Pelli Architects. FDA continued on the project, collaborating with Pelli Clarke Pelli, HKS Architects, and acoustical consultant Jaffe Holden. The Eccles Theater presents touring Broadway productions, nationally prominent family shows, and music and comedy acts. These shows arrive in Salt Lake City much sooner with the new venue, making Broadway more available to all Utahns. The theater also serves as an additional venue for local arts organizations, including Ballet West and Utah Opera. The design of the Utah Performing Arts Center captures the spirit of its place — weaving the theater into downtown Salt Lake City, making connections to recent developments and serving as a catalyst for additional economic growth — a world-class theatre that reflects its surroundings.

  • Client: City of Salt Lake
  • Architect: Pelli Clarke Pelli Architects
  • Arch. of Record: HKS Architects
  • Completion Year: 2016
  • Location: Salt Lake City, Utah
  • Acoustician: Jaffe Holden
  • Capacity: 2,500 seats

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
error: Content is protected. Please reach out to rhackman@fda-online.com for any materials needed. Thank you